Identifying different types of amyloid beta in Alzheimer's plaques
Differentiating Abeta40/42 in plaques with small molecule fluorescent probes
This study is looking at two types of proteins related to Alzheimer's disease to see how they affect brain health, with the hope of finding better ways to diagnose and treat the condition for patients like you.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10507501 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of amyloid beta (Aβ) plaques in Alzheimer's disease by differentiating between two specific types of peptides, Aβ40 and Aβ42, which are found in these plaques. The study employs innovative small-molecule fluorescent probes designed to distinguish between these two peptides, which is crucial since Aβ42 is known to be more neurotoxic than Aβ40. By clarifying the contributions of these peptides to neuron cell death and cognitive decline, the research aims to provide insights that could lead to better diagnostic and therapeutic strategies for Alzheimer's disease. Patients may benefit from advancements in understanding the pathology of their condition through improved imaging techniques.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia or cognitive decline unrelated to amyloid beta pathology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnostics and targeted therapies for Alzheimer's disease.
How similar studies have performed: While the differentiation of Aβ40 and Aβ42 has been challenging, previous studies using antibodies have shown promise, indicating that this approach may yield valuable insights.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Ran, Chongzhao — Massachusetts General Hospital
- Study coordinator: Ran, Chongzhao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.